Stephen Bagley
@StephenBagleyMD
Followers
189
Following
6
Media
0
Statuses
4
Join us at our next Neuro-oncology Brain Tumor Symposium! Penn's multidisciplinary brain tumor team and multiple guests will share the latest in state-of-the-art care with numerous topics being covered. ➡️ https://t.co/IbWFAEHDwf
0
6
35
Our full P1 trial paper now available @NatureMedicine for treatment of recurrent #Glioblastoma completed at @PennMDForum @PennCancer with support from @KitePharma
#cureGBM We see anti tumor responses and have defined dose for ICV #CART cells
0
3
12
Excited to share our early phase 1 results for bivalent #CARTcells in recurrent #glioblastoma. Now online @NatureMedicine. Awesome team effort! @PennMedicine @PennCancer @PennNSG @DrORourke2
https://t.co/xppeeXv74x
nature.com
Nature Medicine - In an interim analysis of an ongoing phase 1 trial of CAR T cells targeting EGFR and IL13Ra2 in patients with multifocal, recurrent glioblastoma, intrathecal delivery is feasible...
6
28
159
Our newest #GBM CART paper now available @NatureCancer. No efficacy signal, but learned a lot about TME thanks to great work of @C_Alanio and others @institut_curie, @parkerici, @PennMedicine, @PennCancer, @MiglioriniDenis, @EJohnWherry, @LabBeatty
https://t.co/8qINwWehMQ
nature.com
Nature Cancer - Bagley et al. conduct a phase 1 trial to study safety and tolerability of CAR T-EGFRvIII cells administered concomitantly with PD-1 inhibition via pembrolizumab in patients with...
6
15
76